Biogen Inc BDR (BIIB34) Stock Price & News

BIIB34:BVMF

Biogen Inc BDR

R$193.80

0.00%

(0.00) 1D

Oct 14, 12:51:04 PM GMT-3 · BRL

All symbols

	Symbol	Price	Change	% Change

Next call in 4 days

Wed, Oct 28, 2:30 PM

Fiscal period

Q3 2026

- / $1.97

Revenue / Est. (USD)

- / 2.63B

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in USD

Loading Previous Earnings...

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.53B	2.28B	2.48B	2.74B
Cost of goods sold	508.60M	443.40M	610.20M	611.60M
Cost of revenue	508.60M	443.40M	610.20M	611.60M
Research and development expenses	431.80M	477.10M	482.20M	492.10M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	592.80M	685.20M	607.30M	709.70M
Operating expense	1.25B	1.36B	1.30B	1.44B
Total operating expenses	1.76B	1.81B	1.91B	2.05B
Operating income	778.60M	471.60M	567.40M	685.60M
Other non operating income	15.80M	17.40M	-1.10M	3.00M
EBT including unusual items	557.30M	-56.00M	377.70M	132.40M
EBT excluding unusual items	748.30M	447.00M	530.10M	625.10M
Income tax expense	90.80M	-7.10M	58.20M	34.90M
Effective tax rate	16.29%	12.68%	15.41%	26.36%
Other operating expenses	87.20M	69.90M	74.20M	68.80M
Net income	466.50M	-48.90M	319.50M	97.50M
Net profit margin	18.40%	-2.15%	12.89%	3.56%
Earnings per share	4.81	1.99	3.57	3.60
Interest and investment income	31.60M	37.20M	37.90M	25.30M
Interest expense	-67.40M	-67.50M	-67.60M	-82.30M
Net interest expenses	-35.80M	-30.30M	-29.70M	-57.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	980.80M	671.80M	771.80M	921.70M
Gain or loss from assets sale	-	-	-	-

Finance